Annex Advisory Services, LLC Gilead Sciences, Inc. Transaction History

Annex Advisory Services, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 22, 2020	SELL	$62.63 - $80.22 $1.36 Million - $1.75 Million	-21,769 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $12.8 Million - $14.1 Million	-208,287 Reduced 90.54%	21,769 $1.42 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $12.8 Million - $14 Million	207,086 Added 901.55%	230,056 $4.46 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $41,381 - $45,678	-662 Reduced 2.8%	22,970 $1.46 Million
Q2 2019 Jul 18, 2019	BUY	$61.87 - $69.38 $32,296 - $36,216	522 Added 2.26%	23,632 $1.6 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $70,533 - $79,016	1,128 Added 5.13%	23,110 $1.5 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $5,932 - $7,742	-98 Reduced 0.44%	21,982 $1.38 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $150,186 - $166,284	2,107 Added 10.55%	22,080 $1.71 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $79,542 - $92,783	1,226 Added 6.54%	19,973 $1.42 Million
Q1 2018 May 03, 2018	BUY	$72.84 - $88.8 $1.37 Million - $1.66 Million	18,747 New	18,747 $1.41 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Annex Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Annex Advisory Services, LLC with notifications on news.